Table 2 The differences in clinicopathological parameters between patients with and without chronic lymphocytic thyroiditis (CLT)
From: The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer
Parameters | Malignancy (+) CLT (-) | Malignancy (+) CLT (+) | Total | P |
|---|---|---|---|---|
(n = 100) | (n = 44) | (n = 144) | ||
Tumor size (cm) | ||||
d ≤2 | 59 (59.0%) | 34 (77.3%) | 93 (64.6%) | 0.073 |
2 < d ≤4 | 28 (28.0%) | 8 (18.2%) | 36 (25.0%) | |
d >4 | 13 (13.0%) | 2 (4.5%) | 15 (10.4%) | |
Multifocality | ||||
No | 79 (79.0%) | 36 (81.8%) | 115 (79.9%) | 0.0871 |
Yes | 21 (21.0%) | 8 (22.2%) | 29 (20.1%) | |
Neck lymph node metastasis | ||||
No | 65 (65.0%) | 25 (56.8%) | 90 (62.5%) | 0.350 |
Yes | 35 (35.0%) | 19 (43.2%) | 54 (37.5%) | |
Gender | ||||
Female | 65 (65.0%) | 41 (93.2%) | 106 (73.6%) | <0.001 |
Male | 35 (35.0%) | 3 (6.8%) | 38 (26.4%) | |
Age | ||||
<45 years | 41 (41.0%) | 22 (50.0%) | 63 (43.7%) | 0.316 |
≥45 years | 59 (59.0%) | 22 (50.0%) | 81 (56.3%) | |
Microcarcinoma | ||||
No | 68 (68.0%) | 30 (68.2%) | 98 (68.1%) | 0.983 |
Yes | 32 (32.0%) | 14 (31.8%) | 46 (31.9%) | |
TNM stage | ||||
I | 57 (68.7%) | 26 (31.3%) | 83 (57.6%) | 0.949 |
II | 23 (67.6%) | 11 (32.4%) | 34 (23.6%) | |
III | 11 (73.3%) | 4 (26.7%) | 15 (10.4%) | |
IVA | 9 (75.0%) | 3 (25.0%) | 12 (8.3%) |